Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial

August 6, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search